EcoDrugPlus

Ribosomal Protein L29

Ensembl ID : ENSPREG00000007066
Gene Symbol: RPL29
3 Cross references
503 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSPREG00000008614
Gene Symbol: RPL30
3 Cross references
415 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSPREG00000010564
Gene Symbol: RPL31
1 Cross references
651 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSPREG00000019431
Gene Symbol: RPL34
3 Cross references
362 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSPREG00000000610
Gene Symbol: RPL35A
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSPREG00000012675
Gene Symbol: RPL36A
4 Cross references
293 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSPREG00000009573
Gene Symbol: RPL38
1 Cross references
322 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSPREG00000012246
Gene Symbol: RPL39
3 Cross references
246 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSPREG00000010449
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSPREG00000008026
Gene Symbol: RPL5
4 Cross references
469 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSPREG00000011393
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSPREG00000017847
Gene Symbol: RPL7
2 Cross references
492 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).